HCPCS code Q0235 — Inj, monoclon antibody, 1 mg. Status: Active. Effective Oct 1, 2025. Source: CMS HCPCS Level II.

Q0235

Active

Inj, monoclon antibody, 1 mg

Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Oct 1, 2025
Code type: alphanumeric
OPPS Status: L — Influenza / pneumococcal vaccines

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q4
    Inj, monoclon antibody, 1 mg